Potential Outcomes Of The ACA’S Third Enrollment Period And Their Implications
The Affordable Care Act’s third enrollment period ends in about a week, but the final outcome is still unclear. While sign-ups have been increasing each week, enrollment could end short of expectations, with consumers facing higher premiums or — contrary to previous patterns — with younger-trending enrollees.
Under Review: How DOJ, FTC Decide Whether To OK Health Insurance Mergers
While some reviews last just 30 days, it could take antitrust regulators more than a year to approve or deny proposed mergers between Anthem and Cigna and Aetna and Humana. An antitrust law expert says that’s because the companies have significant overlap in business products and practices.
Five Things To Watch in Round Three of the ACA’s Open Enrollment
The Affordable Care Act’s third open enrollment period starts on Sunday, and the law faces some new challenges, including a shrinking pool of potential enrollees, shuttering cooperative health plans and a lack of awareness about subsidies that can help consumers purchase coverage.
Apples and Oranges: How Should We Look at Republican, Democratic Health Care Plans?
Republican and Democratic 2016 presidential candidates differ so widely in agenda and ideology that it can be difficult to compare how their health reform plans stack up. But experts say there are some best practices to follow when analyzing the proposals.
Why Expanded Health Care Access for the Undocumented Is Unlikely, Despite Benefits
Research suggests that there are several potential benefits to expanding health care coverage to undocumented immigrants: avoiding a plateau in insurance gains, extending Medicare solvency and others. But expanded access is likely to stall in the face of cost and other concerns.
Why States Using the Federal Exchange Are Unlikely To Run Their Own
Few states using the federal insurance exchange seem willing to establish their own marketplace. That’s even in light of a Supreme Court case that could nullify subsidies for consumers purchasing health insurance through HealthCare.gov, as well as cost such states billions of dollars in assistance and economic gains.
California Supreme Court To Decide Fate of Medical Board’s Access to Rx Database
Some experts say the California Supreme Court should impose further restrictions on access to the state’s prescription drug monitoring database to ensure patient privacy is prioritized. However, others say the public interest of curbing prescription misuse outweighs the argument for increased limitations.